Legal & General Group
JBIO

Legal & General Group’s Jade Biosciences JBIO Stock Holding History

Legal & General Group’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$39.4K Sell
2,805
-1,325
-32% -$19.2K ﹤0.01% 2736
2025
Q4 		$63.7K Buy
4,130
+1,176
+40% +$13.8K ﹤0.01% 2681
2025
Q3 		$25.5K Hold
2,954
– – ﹤0.01% 2946
2025
Q2 		$29.4K Buy
2,954
+2,922
+9,131% +$99.4K ﹤0.01% 2859
2025
Q1 		$2.84K Hold
32
– – ﹤0.01% 3332
2024
Q4 		$2.98K Hold
32
– – ﹤0.01% 3369
2024
Q3 		$2.36K Hold
32
– – ﹤0.01% 3396
2024
Q2 		$1.85K Sell
32
-2
-6% -$1.33K ﹤0.01% 3407
2024
Q1 		$34.8K Sell
34
-14
-29% -$10.7K ﹤0.01% 2824
2023
Q4 		$37.7K Sell
48
-172
-78% -$87.6K ﹤0.01% 2847
2023
Q3 		$104K Buy
220
+55
+33% +$29.8K ﹤0.01% 2825
2023
Q2 		$99K Buy
165
+67
+68% +$42.9K ﹤0.01% 2833
2023
Q1 		$69.2K Buy
98
+6
+7% +$4.98K ﹤0.01% 2828
2022
Q4 		$94.8K Buy
92
+70
+318% +$50.8K ﹤0.01% 2832
2022
Q3 		$13K Buy
22
+10
+83% +$6.68K ﹤0.01% 3294
2022
Q2 		$6K Sell
12
-26
-68% -$12.4K ﹤0.01% 3428
2022
Q1 		$25K Buy
38
+11
+41% +$4.27K ﹤0.01% 3172
2021
Q4 		$11K Hold
27
– – ﹤0.01% 3435
2021
Q3 		$20K Buy
+27
New +$15.1K ﹤0.01% 3269

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Legal & General Group's JBIO Position: Q1 2026 in Review

Legal & General Group reduced its Jade Biosciences (JBIO) stake by 32% in Q1 2026, selling an estimated $19.2K and leaving 2,805 shares worth $39.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2736.

Legal & General Group first reported a position in JBIO in Q3 2021 and has held it in 19 quarters since. The position peaked at $104K in Q3 2023. 120 funds tracked by Wall St. Rank hold JBIO as of Q1 2026.

  • Legal & General Group held 2,805 shares of Jade Biosciences worth $39.4K as of Q1 2026.
  • Legal & General Group sold 1,325 Jade Biosciences shares in Q1 2026, an estimated $19.2K.
  • Jade Biosciences made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2736 holding.
  • Legal & General Group first reported a position in Jade Biosciences in Q3 2021 and has held it in 19 quarters since.
  • Legal & General Group's Jade Biosciences position peaked at $104K in Q3 2023.
  • 120 funds tracked by Wall St. Rank held Jade Biosciences as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.